Adverum Biotechnologies Inc (NASDAQ:ADVM)
| 2.35 Delayed Data As of 3:59pm ET |  +0.03 / +1.29%Today’s Change | 2.26 Today|||52-Week Range 19.25 | -78.32% Year-to-Date |
Latest ADVM News | Press Releases
No recent news for Adverum Biotechnologies Inc.
Today’s Trading
| Previous close | 2.32 |
| Today’s open | 2.33 |
| Day’s range | 2.31 - 2.39 |
| Volume | 162,421 |
| Average volume (3 months) | 2,701,270 |
| Market cap | $229.7M |
Data as of 3:59pm ET, 07/28/2021
Growth & Valuation
| Earnings growth (last year) | -37.19% |
| Earnings growth (this year) | -6.82% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.53 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DRIODarioHealth Corp | +0.25 | +1.73% |
| SRRASierra Oncology Inc | -0.24 | -1.33% |
| CRMDCorMedix Inc | +0.21 | +3.46% |
| IMMPImmutep Ltd | -0.02 | -0.59% |
Data as of 3:59pm ET, 07/28/2021
Financials
| Next reporting date | August 6, 2021 |
| EPS forecast (this quarter) | -$0.38 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$117.5M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Redwood City, California |
Forecasts
